IngredientesCola de caballo (Equisetum arvense) es una planta prehistórica, no floreciente, nativa de América del Norte, Europa y Asia, conocida por sus tallos altos en forma de cepillo y su alto contenido mineral—especialmente sílice. Es una de las especies vegetales supervivientes más antiguas de la Tierra, con una antigüedad de más de 350 millones de años, y es valorada tradicionalmente por sus propiedades diuréticas, astringentes, cicatrizantes y de apoyo al tejido conectivo. Las partes aéreas se utilizan medicinalmente y contienen ácido silícico, flavonoides, alcaloides (incluida la nicotina), saponinas y sales de potasio.
En el herbalismo moderno, la cola de caballo es mejor conocida por apoyar la salud de la piel, el cabello, las uñas, los huesos y el tejido conectivo, principalmente debido a su rico contenido de sílice, que desempeña un papel en la síntesis de colágeno, la resistencia del tejido y la elasticidad. También actúa como un diurético suave, ayudando a aliviar la retención de líquidos, las infecciones del tracto urinario y la inflamación de la vejiga. También puede ayudar en la curación de fracturas, el fortalecimiento de los huesos y la mejora de los esfuerzos de prevención de la osteoporosis cuando se usa junto con calcio y otros minerales.
La cola de caballo se usa comúnmente en cápsulas, tés, tinturas y preparaciones tópicas, y se incluye frecuentemente en mezclas de apoyo para el cabello, la piel y las uñas, o en fórmulas herbales para la salud del tracto urinario.
Uso Histórico
La cola de caballo tiene una larga tradición de uso en el herbalismo occidental, la medicina nativa americana y los remedios populares europeos. Los médicos romanos y griegos antiguos la usaban para detener el sangrado, tratar las úlceras y promover la cicatrización de heridas, particularmente en trastornos hemorrágicos y lesiones traumáticas.
En la Europa medieval, se usaba tanto interna como externamente para afecciones renales y de la vejiga, así como para heridas de cicatrización lenta, afecciones de la piel y uñas quebradizas. Los herbalistas tradicionales también la valoraban para la hematuria (sangre en la orina), la enuresis nocturna y la artritis, gracias a sus cualidades astringentes y de reposición mineral.
Las tribus nativas americanas usaban la cola de caballo como diurético, lavado de heridas y limpiador dental, y la reconocían como una hierba fortalecedora para los huesos y las articulaciones.
Hoy en día, la cola de caballo sigue siendo una hierba popular tanto en aplicaciones cosméticas como terapéuticas, elogiada por sus beneficios impulsados por el sílice para los tejidos estructurales, su suave acción diurética y su papel histórico como tónico mineral natural que apoya los sistemas esquelético y urinario.
Condiciones de salud que cola de caballo puede ayudar a apoyar.
Gastrointestinal side effects—including nausea, cramping, and diarrhoea—are the most consistently documented adverse effects of caprylic acid and MCT oil in human studies. These are dose-dependent and occur particularly when taken on an empty stomach. This well-documented tolerability profile means the gut relationship is scientifically established, though it is an adverse effect rather than a therapeutic benefit.
MCT intake (including C8) reduces subsequent ad libitum energy intake compared to long-chain fats in controlled trials, suggesting an effect on satiety. However, caprylic acid also acylates ghrelin, the hunger-stimulating hormone, creating a mechanistic tension. Net effect on appetite in human trials favors mild suppression when MCTs replace LCTs.
Rxlist/WebMD-level regulatory sources note that caprylic acid might lower blood pressure in some people, but this claim is based on very limited and indirect evidence. No dedicated human RCT establishes blood pressure lowering as a defined effect. The rating 'scientific' is marginal; the evidence is more mechanistic/observational than clinical.
Caprylic acid's rapid conversion to ketones provides an alternative cerebral energy source that may transiently relieve cognitive sluggishness (brain fog) associated with cerebral glucose hypometabolism. Human data supporting this are mostly indirect, derived from MCT/ketone trials in aging and mild cognitive impairment cohorts. Acute benefits within 90 minutes of a C8 dose are reported.
Caprylic acid is an eight-carbon medium-chain fatty acid from coconut oil that disrupts the lipid membranes of Candida cells, causing cell death and inhibiting hyphal growth and biofilm formation in vitro. Multiple laboratory studies confirm antifungal activity against C. albicans. A pediatric RCT found MCT supplementation (including caprylic acid) reduced Candida gastrointestinal colonization in preterm infants.
Caprylic acid (octanoic acid), a medium-chain fatty acid found in coconut oil, has demonstrated antifungal activity against Candida albicans in multiple in vitro studies by disrupting fungal cell membranes and inhibiting hyphal transition and biofilm formation. A 2019 clinical trial in preterm infants showed dietary caprylic/capric acid supplementation produced a highly significant reduction in intestinal Candida burden (rate ratio 0.15; p=0.02), with rapid rebound upon cessation. It is among the most commonly used natural antifungals in Candida cleanse protocols.
Caprylic acid is rapidly converted in liver mitochondria to ketone bodies that enter the TCA cycle directly, bypassing glycolysis, to generate ATP. This is the fundamental mechanism behind MCT use in clinical nutrition for malabsorptive conditions and in ketogenic therapies. Human pharmacokinetic studies confirm efficient ketone production from C8.
A 2015 meta-analysis of 13 RCTs found MCTs (C8/C10) did not significantly alter total cholesterol, LDL, or HDL overall versus LCTs. Animal data show caprylic acid may improve lipid metabolism via ABCA1 upregulation and reduced inflammatory lipid deposition. Human lipid effects of caprylic acid alone are small and inconsistent.
In Alzheimer's disease the brain develops glucose hypometabolism; ketones derived from caprylic acid provide an alternative fuel. Small human trials of MCT formulas containing caprylic acid show improvements in cognitive assessment scores, particularly in APOE4-negative patients. Evidence is promising but limited to small, short studies.
Caprylic acid is rapidly absorbed via the portal vein, bypassing lymphatic transport, and is efficiently converted to ketone bodies in liver mitochondria. Human crossover studies confirm C8 produces a significantly greater ketogenic (plasma beta-hydroxybutyrate) response than C10 or C12, providing a fast-acting alternative fuel source. This underpins its clinical use in fat-malabsorption syndromes and its popular use as an energy supplement.
Caprylic acid (C8) is the principal active fatty acid in the medium-chain triglyceride ketogenic diet (MCT-KD), a clinically established therapy for drug-resistant epilepsy. Animal studies confirm direct anticonvulsant activity independent of ketosis, and it potentiates valproate. Human use of the MCT-KD is supported by decades of paediatric clinical experience, though large RCTs specific to caprylic acid alone remain limited.
Caprylic acid, a medium-chain fatty acid from coconut oil, has in vitro and computational evidence of antifungal action against Candida species and Trichophyton by penetrating and perturbing fungal cell membranes. A 2019 study found it effective at killing Candida albicans. A PMC study (2020) demonstrated it disrupts fungal membranes via steady-state fluorescence anisotropy and is potent against Candida and Trichophyton. It also inhibits virulence factors including morphogenesis and biofilm formation.
Caprylic acid is naturally produced in the gut by anaerobic microbial fermentation and is found at lower levels in IBD patients compared to healthy controls, suggesting it is a marker of a healthy microbiome. In vitro and animal data show antimicrobial selectivity against pathogens including Candida, while preclinical MCT studies show increases in beneficial Akkermansia. Human interventional data are limited.
A meta-analysis of 13 RCTs (n=749) found that MCTs (principally C8 and C10) versus long-chain triglycerides produced a small but significant reduction in body weight (−0.51 kg) and waist circumference (−1.46 cm). Effects are modest and additive to caloric restriction rather than standalone. A retrospective study found MCT supplementation enhanced weight loss on a VLCKD.
Early preclinical and in vitro evidence suggests caprylic acid and MCTs support intestinal barrier function under inflammatory conditions. Animal MCT studies show reduced intestinal permeability and increased Akkermansia abundance. Human-specific evidence is limited to indirect observations from clinical nutrition and IBD metabolomics studies.
MCT oil formulas rich in caprylic acid have shown improvements in working memory and episodic memory in small human trials, most notably in older adults and those with mild cognitive impairment. The mechanism involves ketone-based alternative cerebral fueling. Effects appear strongest when baseline memory is already declining.
Caprylic acid enters liver mitochondria independently of carnitine and generates ketone bodies that fuel mitochondrial ATP synthesis via the TCA cycle. In vitro studies show C8 activates respiratory chain enzyme complexes in hippocampal neurons. Animal data show neuroprotective effects via increased mitochondrial oxygen consumption. Primary human evidence comes from ketogenic diet and MCT studies.
Huang et al. (2011, Archives of Oral Biology) demonstrated that short and medium-chain fatty acids, including caprylic acid, exhibit antimicrobial activity against oral microorganisms including Candida and cariogenic bacteria. Caprylic acid shows anticandidal activity in vitro with MIC values relevant to oral concentrations. Clinical oral use evidence remains primarily in vitro and traditional.
Athlete's foot (tinea pedis) is caused by dermatophytes including Trichophyton species. Caprylic acid's broader antifungal mechanism (membrane disruption) has been demonstrated against Candida and related fungi. Caprylic acid derivatives have shown activity against Trichophyton in preclinical models. Traditional use involves coconut oil (rich in C8) topically for fungal foot infections; dedicated clinical trials are absent.
Caprylic acid's antifungal and antimicrobial properties lead to its use by integrative practitioners for IBS cases believed to involve Candida overgrowth or dysbiosis. Caprylic acid is depleted in IBD stool metabolomics. No RCT has directly tested caprylic acid for IBS symptom relief; the clinical use is based on the Candida–IBS hypothesis and practitioner experience.
Caprylic acid (octanoic acid, a medium-chain fatty acid from coconut oil) is used in natural parasite cleanse protocols for its proposed ability to disrupt Candida and parasite cell membranes. It appears in traditional antiparasitic supplement formulations and is listed in parasite-related herb databases.
Caprylic acid is used by integrative practitioners for small intestinal bacterial/fungal overgrowth based on its broad antimicrobial properties. Its selective activity against Candida and some bacteria, combined with rapid absorption via the portal vein before reaching the distal gut, makes the SIBO rationale less direct than for colonic overgrowth. No human RCT exists for this specific indication.
Caprylic acid's antifungal properties against Candida albicans—the primary cause of vulvovaginal candidiasis—have been established in vitro. Traditional and integrative practitioners use it for vaginal yeast management. Controlled human clinical trials assessing intravaginal caprylic acid are not published; the relationship is grounded in its documented antifungal mechanism and traditional use.
Sistemas corporales que cola de caballo puede ayudar a apoyar.
Volver